Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30011016HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30088012HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30086818HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30076758HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30077839HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067852HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067853HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067854HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067855HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067856HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TCGA Plot Options
Drug Information
GeneCFTR
DrugBank IDDB08820
Drug NameIvacaftor
Target IDBE0001195
UniProt IDP13569
Regulation Typepotentiator
PubMed IDs22293084; 27636560
CitationsYu H, Burton B, Huang CJ, Worley J, Cao D, Johnson JP Jr, Urrutia A, Joubran J, Seepersaud S, Sussky K, Hoffman BJ, Van Goor F: Ivacaftor potentiation of multiple CFTR channels with gating mutations. J Cyst Fibros. 2012 May;11(3):237-45. doi: 10.1016/j.jcf.2011.12.005. Epub 2012 Jan 30.@@Fohner AE, McDonagh EM, Clancy JP, Whirl Carrillo M, Altman RB, Klein TE: PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics. Pharmacogenet Genomics. 2017 Jan;27(1):39-42. doi: 10.1097/FPC.0000000000000246.
GroupsApproved
Direct ClassificationAromatic anilides
SMILESCC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C
Pathways
PharmGKBPA165950341
ChEMBLCHEMBL2010601